Prolonged agonist stimulation does not alter the protein composition of membrane domains in spite of dramatic changes induced in a specific signaling cascade

Cell Biochem Biophys. 2005;42(1):21-40. doi: 10.1385/CBB:42:1:021.

Abstract

Protein composition of membrane domains prepared by three different procedures (mechanical homogenization, alkaline treatment with 1 M Na2CO3 [pH 11.0], or extraction with nonionic detergent Triton X-100), and isolated from the bulk of plasma membranes by flotation on equilibrium sucrose density gradients, was analyzed by two-dimensional (2D) electrophoresis and compared in preparations from control (quiescent) and agonist-stimulated human embryonic kidney cells (HEK)293 or S49 cells. HEK293 cells (clone e2m11) stably expressing high levels of thyrotropin-releasing hormone receptor and G11alpha protein were stimulated by thyrotropin-releasing hormone and S49 lymphoma cells by the beta-adrenergic receptor agonist isoprenaline. Whereas sustained exposure (16 h) of both cell lines to the appropriate hormones led to substantial cellular redistribution and downregulation of the cognate G proteins (G(q)alpha/G11alpha and G(s)alpha, respectively), the distribution and levels of nonstimulated G(i) proteins remained unchanged. The 2D electrophoretic analysis of membrane domains distinguished approx 150-170 major proteins in these structures and none of these proteins was significantly altered by prolonged agonist stimulation. Furthermore, specific immunochemical determination of a number of plasma membrane markers, including transmembrane and glycosyl-phosphatidylinositol-anchored peripheral proteins, confirmed that their detergent-extractability/solubility was not influenced by hormone treatment. Collectively, our present data indicate that sustained hormone stimulation of target cells does not alter the basic protein composition of membrane domain/raft compartments of the plasma membrane in spite of marked changes proceeding in a given signaling cascade.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology*
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Electrophoresis, Gel, Two-Dimensional
  • GTP-Binding Protein alpha Subunits / metabolism*
  • Humans
  • Isoproterenol / pharmacology*
  • Kidney / cytology
  • Lymphoma / pathology
  • Membrane Proteins / metabolism*
  • Protein Structure, Tertiary / drug effects
  • Signal Transduction
  • Thyrotropin-Releasing Hormone / metabolism*

Substances

  • Adrenergic beta-Agonists
  • GTP-Binding Protein alpha Subunits
  • Membrane Proteins
  • Thyrotropin-Releasing Hormone
  • Isoproterenol